Axonics Reports Fourth Quarter and Fiscal Year 2023 Financia

Axonics, Inc. , a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the...

Related Keywords

Boston , Massachusetts , United States , Raymondw Cohen , , Sadie Merger Sub Inc , Medtronic United States Inc , Axonics Inc , Medtronic Inc , Boston Scientific Corporation , Exchange Commission , Party Transactions , Axonic Investor Relations Department , Nasdaq , Medtronic Puerto Rico Operations Co , Medtronic Logistics , Boston Scientific , Securities Litigation Reform Act , Sadie Merger Sub , Merger Sub , Merger Agreement , Medtronic United States , Medtronic Litigation , Annual Report , Proxy Statement , Axonic Investor Relations , Axonic Definitive Proxy Statement , Certain Beneficial Owners , Executive Officers , Axonic Current Report , Initial Statement , Beneficial Ownership , Annual Statement , Comprehensive Income , Months Ended December , Ended December ,